换一批Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.
第一作者：
Desmond G,Powe
第一单位：
Department of Cellular Pathology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, UK and The John van Geest Cancer Research Centre School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS UK.
作者：
医学主题词
肾上腺素能β受体拮抗剂(Adrenergic beta-Antagonists);成年人(Adult);老年人(Aged);乳腺肿瘤(Breast Neoplasms);癌(Carcinoma);无病生存(Disease-Free Survival);减量调节(Down-Regulation);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);高血压(Hypertension);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);肿瘤复发, 局部(Neoplasm Recurrence, Local);存活率分析(Survival Analysis);治疗结果(Treatment Outcome)
DOI
10.18632/oncotarget.197
PMID
21317458
发布时间
2024-05-09
- 浏览51
Oncotarget
628-638页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
